1. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II);Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults;J Am Med Assoc,1993
2. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and Other Societies on Coronary Prevention;Second Joint Task Force of European and Other Societies on Coronary Prevention;Eur Heart J,1998
3. Statin therapy and reductions in low-density lipoprotein cholesterol: Initial clinical data on the potent new statin rosuvastatin;Olsson;Am J Cardiol,2001
4. ZD4522 is superior to atorvastatin in decreasing low-density lipoprotein cholesterol and increasing high-density lipoprotein cholesterol in patients with type IIa or IIb hypercholesterolemia (abstr 1261-175);Davidson;J Am Coll Cardiol,2001
5. ZD4522 is superior to pravastatin and simvastatin in reducing low-density lipoprotein cholesterol, enabling more hypercholesterolemic patients to achieve target low-density lipoprotein cholesterol guidelines (abstr 1261-174);Paoletti;J Am Coll Cardiol,2001